EUVIMEDEUVIMED entdecken
Crossref

Increased Glycogenin‐Exposed Residual Glycogen in Lysosomes Is the Early Pathological Finding in Asymptomatic Pompe Disease

Yixin Shi, Na Zhang, Hanhan Sun, Yunyu Wang, Dandan Zhao, Bing Wen, Chuanzhu Yan, Yuying Zhao, Duoling Li

Muscle & Nerve · 2026-06 · 73 (6) · 1172-1181

DOI: 10.1002/mus.70233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 01.04.2026. Verfasst von Yixin Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerati…. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Glycogen, Lysosomes, Muscle, Skeletal. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of Shandong Province, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Although asymptomatic or pre‐symptomatic Pompe disease is increasingly recognized, early skeletal muscle pathology and the role of residual glycogen at this stage remain unclear. Here, we investigated early muscle pathological changes using human samples and an early‐stage Gaa −/− mouse model, focusing on residual glycogen accumulation.

Methods

Clinical, genetic, imaging, and muscle pathological analyses were performed in an asymptomatic Pompe disease patient carrying a novel GAA variant. Skeletal muscle samples from asymptomatic and symptomatic patients, as well as from early‐stage and late‐stage Gaa −/− mice, were analyzed using histochemistry, immunohistochemistry, immunofluorescence, and Western blotting to assess residual glycogen accumulation and lysosome‐associated pathways.

Results

We identified a novel mutation, c.361C > T, in an asymptomatic Pompe disease patient. Despite the lack of symptoms, residual glycogen accumulated in muscle lysosomes. Immunohistochemistry showed positive glycogenin expression, while LAMP1 and LC3 were negative, suggesting early glycogenin detection. Western blot revealed increased glycogenin and STBD1, with mild LAMP1 and LC3 upregulation. In 1‐month‐old Gaa −/− mice, glycogenin, LAMP1, STBD1, and LC3 were all upregulated. Furthermore, immunofluorescence further showed glycogenin/LAMP1 double‐positive muscle fibers in both the patient and mice.

Discussion

Our study shows that key pathological changes in Pompe disease occur during the asymptomatic stage, with early lysosomal accumulation of residual glycogen. This suggests residual glycogen may serve as a biomarker of early disease activity and a potential target for early intervention, informing disease monitoring and the timing of enzyme replacement therapy (ERT). Further studies are needed to validate its clinical utility and explore strategies for early clearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type IIGlycogenLysosomesMuscle, SkeletalGlycoproteinsAnimalsHumansMiceMice, Knockoutalpha-GlucosidasesMaleFemaleLysosomal Membrane ProteinsDisease Models, AnimalLysosomal-Associated Membrane Protein 1Glucosyltransferases

Stichwörter der Autor:innen

asymptomaticglycophagypomperesidual glycogen

Substanzen

GlycogenglycogeninGlycoproteinsalpha-GlucosidasesLysosomal Membrane ProteinsLysosomal-Associated Membrane Protein 1Glucosyltransferases

Autor:innen und Institutionen

  • Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Jinan, Shandong, Ch…
  • Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Department of Radiology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Förderung

  • National Natural Science Foundation of Shandong Province
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Shi, Y., Zhang, N., Sun, H., Wang, Y., Zhao, D., Wen, B., Yan, C., Zhao, Y., & Li, D. (2026). Increased Glycogenin‐Exposed Residual Glycogen in Lysosomes Is the Early Pathological Finding in Asymptomatic Pompe Disease. Muscle & Nerve, 73(6), 1172-1181. https://doi.org/10.1002/mus.70233

Vancouver

Shi Y, Zhang N, Sun H, Wang Y, Zhao D, Wen B, et al. Increased Glycogenin‐Exposed Residual Glycogen in Lysosomes Is the Early Pathological Finding in Asymptomatic Pompe Disease. Muscle & Nerve. 2026;73(6):1172-1181. doi:10.1002/mus.70233

BibTeX
@article{Shi2026,
  author = {Shi, Yixin and Zhang, Na and Sun, Hanhan and Wang, Yunyu and Zhao, Dandan and Wen, Bing and Yan, Chuanzhu and Zhao, Yuying and Li, Duoling},
  title = {Increased Glycogenin‐Exposed Residual Glycogen in Lysosomes Is the Early Pathological Finding in Asymptomatic Pompe Disease},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {73},
  number = {6},
  pages = {1172--1181},
  doi = {10.1002/mus.70233}
}
Kostenlos starten →